VivoSim Labs, Inc. (VIVS)
0.1561
+0.01
(+7.14%)
USD |
NASDAQ |
Oct 29, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
VivoSim Labs Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2026 | 0.8104 |
| March 27, 2026 | 0.9514 |
| March 26, 2026 | 0.9925 |
| March 25, 2026 | 0.9983 |
| March 24, 2026 | 0.9514 |
| March 23, 2026 | 0.9748 |
| March 20, 2026 | 0.9866 |
| March 19, 2026 | 1.045 |
| March 18, 2026 | 1.057 |
| March 17, 2026 | 1.057 |
| March 16, 2026 | 1.057 |
| March 13, 2026 | 1.057 |
| March 12, 2026 | 1.092 |
| March 11, 2026 | 1.139 |
| March 10, 2026 | 1.116 |
| March 09, 2026 | 1.098 |
| March 06, 2026 | 1.075 |
| March 05, 2026 | 1.104 |
| March 04, 2026 | 1.098 |
| March 03, 2026 | 1.128 |
| March 02, 2026 | 1.292 |
| February 27, 2026 | 1.274 |
| February 26, 2026 | 1.310 |
| February 25, 2026 | 1.204 |
| February 24, 2026 | 1.139 |
| Date | Value |
|---|---|
| February 23, 2026 | 1.157 |
| February 20, 2026 | 1.186 |
| February 19, 2026 | 1.169 |
| February 18, 2026 | 1.122 |
| February 17, 2026 | 1.128 |
| February 13, 2026 | 1.174 |
| February 12, 2026 | 1.122 |
| February 11, 2026 | 1.128 |
| February 10, 2026 | 1.128 |
| February 09, 2026 | 1.145 |
| February 06, 2026 | 1.339 |
| February 05, 2026 | 1.521 |
| February 04, 2026 | 1.38 |
| February 03, 2026 | 1.615 |
| February 02, 2026 | 1.427 |
| January 30, 2026 | 1.715 |
| January 29, 2026 | 0.9983 |
| January 28, 2026 | 1.016 |
| January 27, 2026 | 1.057 |
| January 26, 2026 | 1.016 |
| January 23, 2026 | 1.116 |
| January 22, 2026 | 1.174 |
| January 21, 2026 | 1.169 |
| January 20, 2026 | 1.210 |
| January 16, 2026 | 1.227 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.31 |
| Anika Therapeutics, Inc. | 2.122 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.9235 |
Price to Book Value Related Metrics
| PS Ratio | 4.552 |
| Price | 0.1561 |
| Earnings Yield | -2.86K% |
| Market Cap | 0.4986M |